Ad5-MakGP

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameAd5-MakGP
Drug Alias NameAd5-MakGP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnti-EBOV
TargetsEBOV
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Bioengineering, Academy Of Military Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Bioengineering, Academy Of Military Medical Sciences
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever, Ebola
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A